Related Experiment Video
Updated: Aug 11, 2026

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
Modification of chronotropic response to anticholinergics by halogenated anaesthetics in children
Insights
In pediatric patients, enflurane anesthesia combined with anticholinergic drugs resulted in a lower heart rate increase compared to halothane. This combination offers an advantage when managing tachycardia risks in children.
Area of Science:
- Anesthesiology
- Pediatric Cardiology
Background:
- Anticholinergic medications like atropine and glycopyrrolate are used to manage bradycardia and secretions during anesthesia.
- Halothane and enflurane are volatile anesthetic agents with differing effects on the cardiovascular system.
Purpose of the Study:
- To compare the effects of atropine and glycopyrrolate on heart rate and rhythm in children.
- To evaluate the influence of halothane versus enflurane anesthesia on anticholinergic-induced tachycardia in pediatric patients.
Main Methods:
- 40 pediatric patients received intravenous atropine or glycopyrrolate post-induction with halothane or enflurane.
- Standardized premedication and controlled ventilation to maintain normal end-tidal carbon dioxide levels were employed.
- Cardiac rate, rhythm, and occurrence of arrhythmias were monitored.
Main Results:
- Heart rate increased in all children after anticholinergic administration.
- The increase in heart rate was significantly greater in the halothane group compared to the enflurane group.
- No significant difference in heart rate increase was observed between atropine and glycopyrrolate.
- Junctional tachycardia was the sole arrhythmia observed, with no significant difference in frequency across groups.
Conclusions:
- Enflurane anesthesia combined with anticholinergic drugs leads to less pronounced tachycardia than halothane in pediatric patients.
- This combination may be advantageous in pediatric anesthesia when minimizing tachycardia is a clinical concern.
Abstract:
Cardiac rate and rhythm changes were studied in 40 children after intravenous injection of atropine or glycopyrrolate following induction of anaesthesia with halothane and enflurane. Premedication was standardized in all groups and ventilation controlled to achieve normal end tidal carbon dioxide. Heart rate increased in all cases following anticholinergic medication and the increase in heart rate was significantly higher in children receiving halothane anaesthesia as compared to those given enflurane. There was no significant difference between atropine and glycopyrrolate groups. There was no difference in frequency of occurrence of junctional tachycardia, which was the only arrhythmia observed, in the four groups studied. Our findings suggest that, in clinical situations where development of marked tachycardia is a concern, the combination of enflurane and anticholinergic drugs offers an advantage over the combination of halothane and anticholinergic drugs in paediatric patients.
More Related Videos
Related Concept Videos
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Cholinergic Antagonists: Pharmacokinetics
Cholinergic Antagonists: Pharmacological Actions
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...

